期刊的影响因子--文章列表

期刊文章列表
Xu-Nian Wu，Qian Zhou，Ya-Dan Huang，Xi Xie，Zhe Li，Yinuo Wu，Hai-Bin Luo（School of Pharmaceutical Sciences）.Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia[J].药学学报(英文版),2022,第7期 Yuhong Cao，Jiahao Fang，Yiwei Shi，Hui Wang，Xiaofei Chen，Yue Liu，Zhenyu Zhu，Yan Cao，Zhanying Hong，Yifeng Chai（School of Pharmacy）.Screening potential P-glycoprotein inhibitors by combination of a detergent-free membrane protein extraction with surface plasmon resonance biosensor[J].药学学报(英文版),2022,第7期 Qichao Yang，Xianbin Ma，Yao Xiao，Tian Zhang，Leilei Yang，Shaochen Yang，Mengyun Liang，Shuo Wang，Zhizhong Wu，Zhigang Xu，Zhijun Sun（The State Key Laboratory Breeding Base of Basic Science of Stomatology（Hubei-MOST）&Key Laboratory of Oral Biomedicine Ministry of Education）.Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity[J].药学学报(英文版),2022,第7期 Fenglin Jiang，Chen Zhou，Yan Li，Haidong Deng，Ting Gong，Jingjing Chen，Tianjiao Chen，Jinling Yang，Ping Zhu（State Key Laboratory of Bioactive Substance and Function of Natural Medicines）.Metabolic engineering of yeasts for green and sustainable production of bioactive ginsenosides F2 and 3β,20S-Di-O-Glc-DM[J].药学学报(英文版),2022,第7期 Jian He，Yu Huo，Zhikun Zhang，Yiqun Luo，Xiuli Liu，Qiaoying Chen，Pan Wu，Wei Shi，Tao Wu，Chao Tang，Huixue Wang，Lan Li，Xiyu Liu，Yong Huang，Yongxiang Zhao，Lu Gan，Bing Wang，Liping Zhong（National Center for International Research of Biotargeting Theranostics）.Generation ofαGal-enhanced bifunctional tumor vaccine[J].药学学报(英文版),2022,第7期 Sinan Ma，Jianai Ji，Yuanyuan Tong，Yuxuan Zhu，Junwei Dou，Xian Zhang，Shicheng Xu，Tianbao Zhu，Xiaoli Xu，Qidong You，Zhengyu Jiang（State Key Laboratory of Natural Medicines and Jiang Su Key Laboratory of Drug Design and Optimization）.Non-small molecule PROTACs(NSM-PROTACs)：Protein degradation kaleidoscope[J].药学学报(英文版),2022,第7期 Xiaoting Shan，Xiang Gong，Jie Li，Jingyuan Wen，Yaping Li，Zhiwen Zhang（State Key Laboratory of Drug Research&Center of Pharmaceutics）.Current approaches of nanomedicines in the market and various stage of clinical translation[J].药学学报(英文版),2022,第7期 Ningna Weng，Siyuan Qin，Jiayang Liu，Xing Huang，Jingwen Jiang，Li Zhou，Zhe Zhang，Na Xie，Kui Wang，Ping Jin，Maochao Luo，Liyuan Peng，Edouard C.Nice，Ajay Goel，Suxia Han，Canhua Huang，Qing Zhu（Department of Abdominal Oncology）.Repurposing econazole as a pharmacological autophagy inhibitor to treat pancreatic ductal adenocarcinoma[J].药学学报(英文版),2022,第7期 Siyue Zhang，Fangyuan Xie，Kaichun Li，He Zhang，You Yin，Yuan Yu，Guangzhao Lu，Shihao Zhang，Yan Wei，Ke Xu，Yan Wu，Hong Jin，Lan Xiao，Leilei Bao，Can Xu，Yulin Li，Ying Lu，Jie Gao（Department of Pharmacy）.Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization[J].药学学报(英文版),2022,第7期 Tianming Ren，Runzhi Li，Liqiang Zhao，J.Paul Fawcett，Dong Sun，Jingkai Gu（Research Center for Drug Metabolism）.Biological fate and interaction with cytochromes P450 of the nanocarrier material,D-α-tocopheryl polyethylene glycol 1000 succinate[J].药学学报(英文版),2022,第7期 Bin Tu，Huiyuan Wang，Xinran An，Jingkun Qu，Qianqian Li，Yanrong Gao，Mingjie Shi，Hong Qiu，Yongzhuo Huang（State Key Laboratory of Drug Research）.Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants[J].药学学报(英文版),2022,第7期 Yi Zhu，Na Li，Mingyang Huang，Xi Chen，Yu A.An，Jianping Li，Shangang Zhao，Jan-Bernd Funcke，Jianhong Cao，Zhenyan He，Qingzhang Zhu，Zhuzhen Zhang，Zhao V.Wang，Lin Xu，Kevin W.Williams，Chien Li，Kevin Grove，Philipp E.Scherer（Touchstone Diabetes Center）.Activating Connexin43 gap junctions primes adipose tissue for therapeutic intervention[J].药学学报(英文版),2022,第7期 Ziying Sun，Qianqian Liu，Zhongyang Lv，Jiawei Li，Xingquan Xu，Heng Sun，Maochun Wang，Kuoyang Sun，Tianshu Shi，Zizheng Liu，Guihua Tan，Wenqiang Yan，Rui Wu，Yannick Xiaofan Yang，Shiro Ikegawa，Qing Jiang，Yang Sun，Dongquan Shi（State Key Laboratory of Pharmaceutical Biotechnology）.Targeting macrophagic SHP2 for ameliorating osteoarthritis via TLR signaling[J].药学学报(英文版),2022,第7期 Ashima Dhiman，Rupam Sharma，Rajesh K.Singh（Department of Pharmaceutical Chemistry）.Target-based anticancer indole derivatives and insight into structure-activity relationship：A mechanistic review update(2018—2021)[J].药学学报(英文版),2022,第7期 Duxin Sun，Wei Gao，Hongxiang Hu，Simon Zhou（Department of Pharmaceutical Sciences）.Why 90%of clinical drug development fails and how to improve it?[J].药学学报(英文版),2022,第7期 Yunhao Wu，Xiu Yu，Yuwei Wang，Yalin Huang，Jiahui Tang，Shuaishuai Gong，Siyu Jiang，Yuanli Xia，Fang Li，Boyang Yu，Yuanyuan Zhang，Junping Kou（State Key Laboratory of Natural Medicines）.Author correction to'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TL R4 signaling’[Acta Pharmaceutica Sinica B 12(2022)1198-1212][J].药学学报(英文版),2022,第7期 Qing He，Hua Gao，Dejiang Tan，Heng Zhang，Jun-zhi Wang（National Institutes for Food and Drug Control）.mRNA cancer vaccines：Advances,trends and challenges[J].药学学报(英文版),2022,第7期 Shuai Yang，Lu Chen，Ying Tong，Wenqiang Yu（Laboratory of RNA Epigenetics）.Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19[J].药学学报(英文版),2022,第7期 Yun Yang，Danrong Hu，Yi Lu，Bingyang Chu，Xinlong He，Yu Chen，Yao Xiao，Chengli Yang，Kai Zhou，Liping Yuan，Zhiyong Qian（State Key Laboratory of Biotherapy and Cancer Center West China Hospital，Sichuan University，Collaborative Innovation Center of Biotherapy，Chengdu 610041，China；West China School of Pharmacy，Sichuan University，Chengdu 610041，China）.Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy[J].药学学报(英文版),2022,第6期 Wei Wang，Shuo Feng，Zhuyifan Ye，Hanlu Gao，Jinzhong Lin，Defang Ouyang（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau，Macau 999078，China；State Key Laboratory of Genetic Engineering，School of Life Sciences，Zhongshan Hospital，Fudan University，Shanghai 200438，China）.Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm[J].药学学报(英文版),2022,第6期 Ozioma Udochukwu Akakuru，Zhoujing Zhang，M.Zubair Iqbal，Chengjie Zhu，Yewei Zhang，Aiguo Wu（Cixi Institute of Biomedical Engineering，International Cooperation Base of Biomedical Materials Technology and Application，Chinese Academy of Sciences(CAS)Key Laboratory of Magnetic Materials and Devices，Zhejiang Engineering Research Center for Biomedical Materials，Ningbo Institute of Materials Technology and Engineering，CAS，Ningbo 315201，China；School of Medicine，Southeast University，Nanjing 210009，China；Cixi Institute of Biomedical Engineering，International Cooperation Base of Biomedical Materials Technology and Application，Chinese Academy of Sciences(CAS)Key Laboratory of Magnetic Materials and Devices，Zhejiang Engineering Research Center for Biomedical Materials，Ningbo Institute of Materials Technology and Engineering，CAS，Ningbo 315201，China；School of Materials Science and Engineering，Zhejiang Sci-Tech University，Hangzhou 310018，China）.Chemotherapeutic nanomaterials in tumor boundary delineation：Prospects for effective tumor treatment[J].药学学报(英文版),2022,第6期 Ying Wu，Congying Pu，Yixian Fu，Guoqiang Dong，Min Huang，Chunquan Sheng（School of Pharmacy，Second Military Medical University，Shanghai 200433，China；State Key Laboratory of Drug Research，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，University of Chinese Academy of Sciences，Shanghai 201203，China）.NAMPT-targeting PROTAC promotes antitumor immunity via suppressing myeloid-derived suppressor cell expansion[J].药学学报(英文版),2022,第6期 Haiming Xiao，Xiaohong Sun，Zeyuan Lin，Yan Yang，Meng Zhang，Zhanchi Xu，Peiqing Liu，Zhongqiu Liu，Heqing Huang（Laboratory of Pharmacology&Toxicology，School of Pharmaceutical Sciences，Sun Yat-sen University，Guangzhou 510006，China；National and Local United Engineering Lab of Druggability and New Drugs Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University，Guangzhou 510006，China；Laboratory of Pharmacology&Toxicology，School of Pharmaceutical Sciences，Sun Yat-sen University，Guangzhou 510006，China；School of Pharmaceutical Sciences，Guangzhou University of Chinese Medicine，Guangzhou 510006，China）.Gentiopicroside targets PAQR3 to activate the PI3K/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism[J].药学学报(英文版),2022,第6期 Tingting Yang，Yuzhu Hu，Junming Miao，Jing Chen，Jiagang Liu，Yongzhong Cheng，Xiang Gao（Department of Neurosurgery and Institute of Neurosurgery，State Key Laboratory of Biotherapy and Cancer Center West China Hospital，West China Medical School，Sichuan University and Collaborative Innovation Center for Biotherapy，Chengdu 610041，China；Department of Neurosurgery and Institute of Neurosurgery，State Key Laboratory of Biotherapy and Cancer Center West China Hospital，West China Medical School，Sichuan University and Collaborative Innovation Center for Biotherapy，Chengdu 610041，China；Department of Medical Oncology，State Key Laboratory of Biotherapy and Cancer Center West China Hospital，West China Medical School，Sichuan University and Collaborative Innovation Center for Biotherapy，Chengdu 610041，China）.A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation,apoptosis and M2 macrophages polarization[J].药学学报(英文版),2022,第6期 Menghuan Tang，Kai Lin，Mythili Ramachandran，Longmeng Li，Hongye Zou，Huzhi Zheng，Zhao Ma，Yuanpei Li（Key Laboratory of Luminescent and Real-Time Analytical Chemistry，Ministry of Education，College of Chemistry and Chemical Engineering，Southwest University，Chongqing 400715，China；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine，Sacramento，CA 95817，USA；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine，Sacramento，CA 95817，USA；College of Food Science and Engineering，Ocean University of China，Qingdao 266003，China；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine，Sacramento，CA 95817，USA；Key Laboratory of Luminescent and Real-Time Analytical Chemistry，Ministry of Education，College of Chemistry and Chemical Engineering，Southwest University，Chongqing 400715，China；Department of Biochemistry and Molecular Medicine，UC Davis School of Medicine，Sacramento，CA 95817，USA；Department of Medicinal Chemistry，Key Laboratory of Chemical Biology(MOE)，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University，Jinan 250012，China）.A mitochondria-targeting lipid——small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model[J].药学学报(英文版),2022,第6期 Jingya Zhao，Huabei Huang，Jinyan Zhao，Xiang Xiong，Sibo Zheng，Xiaoqing Wei，Shaobing Zhou（Key Laboratory of Advanced Technologies of Materials，Ministry of Education，School of Materials Science and Engineering，Southwest Jiaotong University，Chengdu 610031，China）.A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy[J].药学学报(英文版),2022,第6期 Jiayi Ye，Bo Hou，Fangmin Chen，Shunan Zhang，Muya Xiong，Tianliang Li，Yechun Xu，Zhiai Xu，Haijun Yu（State Key Laboratory of Drug Research&Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；State Key Laboratory of Drug Research&Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；School of Chemistry and Molecular Engineering，East China Normal University，Shanghai 200241，China；University of Chinese Academy of Sciences，Beijing 100049，China；CAS Key Laboratory of Receptor Research，and Drug Discovery and Design Center Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201210，China；State Key Laboratory of Drug Research&Center of Pharmaceutics，Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201203，China；University of Chinese Academy of Sciences，Beijing 100049，China；CAS Key Laboratory of Receptor Research，and Drug Discovery and Design Center Shanghai Institute of Materia Medica，Chinese Academy of Sciences，Shanghai 201210，China；School of Pharmaceutical Science and Technology，Hangzhou Institute for Advanced Study，University of Chinese Academy of Sciences，Hangzhou 310013，China；School of Chemistry and Molecular Engineering，East China Normal University，Shanghai 200241，China）.Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy[J].药学学报(英文版),2022,第6期 Ying Liu，Yu Han，Shizhu Chen，Jingjie Liu，Dajiang Wang，Yifei Huang（Department of Ophthalmology，Beijing Rehabilitation Hospital，Capital Medical University，Beijing 100144，China；Department of Ophthalmology，Chinese PLA General Hospital，Beijing 100853，China；College of Chemistry&Environmental Science，Chemical Biology Key Laboratory of Hebei Province，Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education，Hebei University，Baoding 071002，China；China Resources Pharmaceutical Group Limited，Beijing 100000，China；Department of Ophthalmology，Chinese PLA General Hospital，Beijing 100853，China）.Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma[J].药学学报(英文版),2022,第6期 Debin Zheng，Jingfei Liu，Limin Xie，Yuhan Wang，Yinghao Ding，Rong Peng，Min Cui，Ling Wang，Yongjie Zhang，Chunqiu Zhang，Zhimou Yang（Key Laboratory of Bioactive Materials，Ministry of Education，State Key Laboratory of Medicinal Chemical Biology，College of Life Sciences，Collaborative Innovation Center of Chemical Science and Engineering，National Institute of Functional Materials，Nankai University，Tianjin 300071，China；College of Pharmacy，Nankai University，Tianjin 300071，China；Department of Human Anatomy，Nanjing Medical University，Nanjing 211166，China）.Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death[J].药学学报(英文版),2022,第6期首页上一页 2 3 4 5 6 下一页尾页共有11页，转到页

期刊文章列表